AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 327 filers reported holding AMEDISYS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,172,000 | +6.6% | 238,971 | +1.6% | 0.21% | +24.9% |
| Q4 2021 | $38,612,000 | -11.4% | 235,253 | -19.5% | 0.17% | -14.2% |
| Q3 2021 | $43,594,000 | -39.6% | 292,385 | -0.8% | 0.20% | -36.5% |
| Q2 2021 | $72,159,000 | -9.2% | 294,613 | -0.1% | 0.31% | -11.9% |
| Q1 2021 | $79,434,000 | -38.9% | 294,790 | -33.5% | 0.35% | -52.0% |
| Q4 2020 | $130,080,000 | +14.3% | 443,462 | -9.6% | 0.73% | +25.3% |
| Q3 2020 | $113,844,000 | +6.7% | 490,623 | -9.2% | 0.59% | -3.5% |
| Q2 2020 | $106,670,000 | +90.1% | 540,184 | +76.7% | 0.61% | +73.9% |
| Q1 2020 | $56,121,000 | +16.8% | 305,773 | +6.2% | 0.35% | +51.1% |
| Q4 2019 | $48,038,000 | +26.5% | 287,792 | -0.7% | 0.23% | +17.9% |
| Q3 2019 | $37,986,000 | +7.4% | 289,952 | -0.4% | 0.20% | +8.3% |
| Q2 2019 | $35,359,000 | – | 291,242 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
| Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
| Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
| RK Capital | 54,900 | $9,459,000 | 1.86% |
| Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
| Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
| Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
| Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
| Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
| Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |